


Healthcare News Roundup: Neuro
HSMN NewsFeed - 15 Aug 2008
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
HSMN NewsFeed - 6 Aug 2008
IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
HSMN NewsFeed - 5 Aug 2008
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
HSMN NewsFeed - 31 Jul 2008
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
Sierra Neuropharmaceuticals Completes $21.5-Million Series A Funding Round
HSMN NewsFeed - 30 Jul 2008
New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
HSMN NewsFeed - 28 Jul 2008
Concentric Medical Launches Next Generation Family of Neurovascular Retrievers
Concentric Medical Launches Next Generation Family of Neurovascular Retrievers
HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
HSMN NewsFeed - 22 Jul 2008
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis
Biogen Idec and Elan Celebrate Second Anniversary of TYSABRI(R) for the Treatment of Multiple Sclerosis
HSMN NewsFeed - 21 Jul 2008
ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International
ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International
HSMN NewsFeed - 17 Jul 2008
Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
HSMN NewsFeed - 15 Jul 2008
SpineWorks Medical, Inc. Announces CE-Mark for SpineAlign(TM) Vertebral Body Replacement System
SpineWorks Medical, Inc. Announces CE-Mark for SpineAlign(TM) Vertebral Body Replacement System
HSMN NewsFeed - 14 Jul 2008
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
HSMN NewsFeed - 10 Jul 2008
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
HSMN NewsFeed - 8 Jul 2008
Ascension's 3D Guidance medSAFE(tm) Advancing Earlier Diagnosis of Infantile Cerebral Palsy
Ascension's 3D Guidance medSAFE(tm) Advancing Earlier Diagnosis of Infantile Cerebral Palsy
HSMN NewsFeed - 2 Jul 2008
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for Neurosurgery
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for Neurosurgery
HSMN NewsFeed - 1 Jul 2008
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
HSMN NewsFeed - 25 Jun 2008
TranS1 Inc. Announces the First Patients Treated With Its Percutaneous Nucleus Replacement, PNR, in Europe
TranS1 Inc. Announces the First Patients Treated With Its Percutaneous Nucleus Replacement, PNR, in Europe
HSMN NewsFeed - 24 Jun 2008
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics, Inc.
Novel Progesterone Formulation for Stroke and Traumatic Brain Injury Developed by Encore Therapeutics, Inc.
HSMN NewsFeed - 23 Jun 2008
Orthofix International Acquires Intellectual Property For Next Generation Spinal System
Orthofix International Acquires Intellectual Property For Next Generation Spinal System
